ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 637659 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 637659; 2) Community: the network communities that were significantly associated with the response to NSC 637659; 3) Molecule: the relationships between components within communities and NSC 637659; 4) MDR: the compounds that were significantly associated with the NSC 637659.

NSC Compound Enrichment Correlation
NSC 733476 Null 0.0392716453377535 0.32103809
NSC 741425 3,7-di(trifluoromethyl)-2-naftoylquioxaline 1,4-dioxide 0.0392716453377535 0.3045056
NSC 750873 2,5-anhydro-1-(3,4,5-trimethoxyphenyl)-1-(3-hydroxy-4-methoxyphenyl)-1-desoxy-3.4:6.7-di-O-isopropylidene-L-glucohept-1-enitol 0.0392716453377535 -0.057284246
NSC 100880 Camptothecin 0.0403978426119736 0.08305408
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.0403978426119736 0.40288738
NSC 163443 Null 0.0403978426119736 0.13095689
NSC 185065 Hydrazinecarbothioamide, 2-[(5-hydroxy-2-pyridinyl)methylene]-N-(3-pyridinyl)- 0.0403978426119736 0.30888018
NSC 18805 .gamma.-Thujaplicine 0.0403978426119736 0.27301406
NSC 354974 Acetamide, N-(5,6,7,9-tetrahydro-2,3-dihydroxy-1,10-dimethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- 0.0403978426119736 -0.1769402
NSC 5332 2-Hydroxy-1-(2-pyridylazo)naphthalene 0.0403978426119736 0.30544521
Total:43  Current:35    [First] [Prev] [Next] [Last]